Non–Small-Cell Lung Cancer GUIDELINES Pocket Card
Stage IV Chemotherapy

The Non–Small-Cell Lung Cancer: Stage IV Chemotherapy GUIDELINES Pocket Card™ is endorsed by the American Society of Clinical Oncology (ASCO) and based on ASCO’s latest guidelines. It contains recommendations for 1st, 2nd and 3rd line treatment, a table of treatment regimens, a comprehensive management algorithm and a discussion of molecular analysis. The Non–Small-Cell Lung Cancer: Stage IV Chemotherapy GUIDELINES Pocket Ccard™ provides all that is needed to make accurate clinical decisions at the point of care.

• Recommendations for 1st, 2nd and 3rd Line Treatment
• Comprehensive Management Algorithm
• Table of Treatment Regimens
• Discussion of Molecular Analysis

• Multifold
• 8 pages
• 80# Diamond Silk Cover with Satin Aqueous Coating
• 4.25" x 7.25"

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. Nearly 30,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.

The Non-Small-Cell Lung Cancer Digital GUIDELINE subscription contains the same great content included in the printed pocket cards, only in a digital format. This eGUIDELINE can be accessed anywhere, anytime, and on any device.

• Subscription Length: 6 months
• Price: $3.99
• Automatic Updates: Yes
• Plays On: Desktop, Laptop, iPhone, iPad, Android
• Internet Connection Required
• Web App URL (and preview) - Click Here

We also offer special pricing for institutional and group licenses - call us today to learn more.